Cardiac ryanodine receptor in metabolic syndrome: is JTV519 (K201) future therapy?

Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy
U Deniz Dincer

Abstract

Metabolic syndrome is characterized by a combination of obesity, hypertension, insulin resistance, dyslipidemia, and impaired glucose tolerance. This multifaceted syndrome is often accompanied by a hyperdynamic circulatory state characterized by increased blood pressure, total blood volume, cardiac output, and metabolic tissue demand. Experimental, epidemiological, and clinical studies have demonstrated that patients with metabolic syndrome have significantly elevated cardiovascular morbidity and mortality rates. One of the main and frequent complications seen in metabolic syndrome is cardiovascular disease. The primary endpoints of cardiometabolic risk are coronary and peripheral arterial disease, myocardial infarction, congestive heart failure, arrhythmia, and stroke. Alterations in expression and/or functioning of several key proteins involved in regulating and maintaining ionic homeostasis can cause cardiac disturbances. One such group of proteins is known as ryanodine receptors (intracellular calcium release channels), which are the major channels through which Ca(2+) ions leave the sarcoplasmic reticulum, leading to cardiac muscle contraction. The economic cost of metabolic syndrome and its associated complications has a ...Continue Reading

References

Nov 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·S FleischerE A Fleer
Apr 1, 1995·Proceedings of the Society for Experimental Biology and Medicine·J E HallM Alonso Galicia
Oct 1, 1995·Clinical and Experimental Pharmacology & Physiology·J E HallM Alonso-Galicia
Oct 6, 1997·The Journal of Biological Chemistry·A J LokutaH H Valdivia
Mar 30, 2001·The Journal of Biological Chemistry·M GaburjakovaA R Marks
Apr 20, 2001·The American Journal of the Medical Sciences·M A Alpert
Feb 28, 2003·The Journal of Pharmacology and Experimental Therapeutics·Keshore R BidaseeU Deniz Dincer
Apr 23, 2003·The Journal of Biological Chemistry·Naohiro YamaguchiGerhard Meissner
Jun 26, 2003·The Journal of Biological Chemistry·Emily F FarrellHéctor H Valdivia
Mar 16, 2004·Circulation Research·Xander H T WehrensAndrew R Marks
Jun 18, 2004·Annals of the New York Academy of Sciences·Stephan E LehnartAndrew R Marks
Nov 5, 2004·Molecular and Cellular Biochemistry·Sahika GunerU Deniz Dincer
Mar 8, 2005·American Journal of Physiology. Heart and Circulatory Physiology·Jarrod D KnudsonJohnathan D Tune
Apr 16, 2005·Cardiology in Review·Ying Taur, William H Frishman
Apr 29, 2005·International Journal of Clinical Practice·L R Erhardt
May 17, 2005·American Journal of Physiology. Heart and Circulatory Physiology·Jarrod D KnudsonJohnathan D Tune
Dec 24, 2005·Cardiology in Review·Mark J Eisenberg, Laura C Gioia
Jan 13, 2006·Proceedings of the National Academy of Sciences of the United States of America·Xander H T WehrensAndrew R Marks
Mar 18, 2006·Circulation Research·Indu G PoornimaRichard P Shannon
Apr 22, 2006·Microcirculation : the Official Journal of the Microcirculatory Society, Inc·Jarrod D KnudsonJohnathan D Tune
May 5, 2006·Proceedings of the National Academy of Sciences of the United States of America·Stephan E LehnartAndrew R Marks
Aug 29, 2006·Nature Reviews. Molecular Cell Biology·Joerg Heineke, Jeffery D Molkentin
Sep 23, 2006·Microcirculation : the Official Journal of the Microcirculatory Society, Inc·U Deniz DincerJohnathan D Tune
Jan 4, 2007·The Journal of Biological Chemistry·Spyros ZissimopoulosF Anthony Lai
Mar 27, 2007·The Journal of Pediatrics·Elizabeth GoodmanLawrence M Dolan
Apr 5, 2007·Current Medical Research and Opinion·Richard E Pratley, Afshin Salsali
Apr 14, 2007·The Journal of Clinical Investigation·Naohiro YamaguchiGerhard Meissner
Jul 7, 2007·Microcirculation : the Official Journal of the Microcirculatory Society, Inc·Jarrod D KnudsonJohnathan D Tune
Sep 9, 2008·Endocrinology and Metabolism Clinics of North America·Emily Jane GallagherEddy Karnieli

❮ Previous
Next ❯

Citations

Jun 25, 2013·Pharmacology & Therapeutics·Dimitrios M KonstantinouGeorge D Giannoglou
Aug 8, 2015·Progress in Cardiovascular Diseases·Sandeep PrabhuPeter M Kistler
Feb 7, 2013·Pharmacology & Therapeutics·Jérémy FauconnierAlain Lacampagne
Jul 18, 2019·PloS One·José A Serrano-SánchezAntonio Cabrera de León
Jun 27, 2019·Proceedings of the National Academy of Sciences of the United States of America·Sun-Ji ParkYing Maggie Chen
Feb 15, 2013·Cardiovascular Research·Andriy E BelevychSandor Györke
May 23, 2019·Frontiers in Physiology·Gaudencio Fernández-MirandaAngélica Rueda
Sep 2, 2018·Hormones : International Journal of Endocrinology and Metabolism·Uzma ZafarKhalid P Lone

❮ Previous
Next ❯

Methods Mentioned

BETA
percutaneous transluminal coronary angioplasty

Software Mentioned

SOLD
CONSENSUS
SOLVD
HeFT
Val
CHARM

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Related Papers

Advances in Pharmacology
Alexander Kushnir, Andrew R Marks
Journal of Molecular and Cellular Cardiology
U Deniz DincerJohnathan D Tune
Recent Patents on Biotechnology
Alexander Kushnir, Andrew R Marks
Expert Opinion on Therapeutic Targets
Sheila A Doggrell
© 2021 Meta ULC. All rights reserved